SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON
The reason for the Systemic Anti-Cancer Therapy Drug Regimen upfront dose modification.
Description
The reason for the Systemic Anti-Cancer Therapy Drug Regimen upfront dose modification.
For further guidance on recording of the National Codes, see the User Guidance provided by the National Disease Registration Service at: Downloads and guides.
National Codes
| Code | Description |
|---|---|
| 1 | PATIENT choice |
| 2 | ORGANISATION (Trust) issues |
| 3 | PATIENT (Clinical) factors |
| 4 | Toxicity |
Where Used
| Type | Link | How used |
|---|---|---|
| Class | ACTIVITY DRUG | has an attribute SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON of type SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON |
| Data Element | COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION) | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON |
| Attribute | SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN PATIENT CLINICAL FACTORS UPFRONT DOSE MODIFICATION REASON | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON |
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON |